20th Aug 2007 15:04
Smith & Nephew Plc20 August 2007 Investor visit to Smith & Nephew Endoscopy 20 August 2007 Smith & Nephew plc, (LSE: SN, NYSE: SNN), the global medical technologybusiness, will be holding a visit for institutional investors and analysts atthe global headquarters of the company's Endoscopy business in Boston,Massachusetts, on Tuesday 18 September 2007. The visit will be hosted by Chief Executive, David Illingworth, and MikeFrazzette, President of Smith & Nephew Endoscopy. During the visit guests willhave the opportunity to meet senior management and receive presentations fromthe heads of the Endoscopy business. The main presentations of the event will be webcast live on Smith & Nephew'scorporate website at www.smith-nephew.com and will begin at 1.15pm BST/7.15amCST/8.15am EST on Tuesday 18 September 2007. An archive of these presentationswill be available on the website shortly after the close. Enquiries Julie Allen Tel: +44 (0) 20 7401 7646Corporate Affairs Co-ordinator About us Smith & Nephew (LSE: SN.L; NYSE: SNN) is one of the world's leading medicaldevice companies, specialising in Orthopaedic Reconstruction, Orthopaedic Traumaand Clinical Therapies, Endoscopy and Advanced Wound Management. Smith & Nephewis a global leader in arthroscopy and advanced wound management and is one ofthe leading global orthopaedics companies. Smith & Nephew is dedicated to helping improve people's lives. The companyprides itself on the strength of its relationships with its surgeon andhealthcare professional customers, with whom its name is synonymous with thehighest standards of performance, innovation and trust. The company has over9,600 employees and operates in 31 countries around the world, generating salesof $2.8 billion. Forward-Looking Statements This press release contains certain "forward-looking statements" within themeaning of the US Private Securities Litigation Reform Act of 1995. Inparticular, statements regarding expected revenue growth and trading marginsdiscussed under "Outlook" are forward-looking statements as are discussions ofour product pipeline. These statements, as well as the phrases "aim", "plan","intend", "anticipate", "well-placed", "believe", "estimate", "expect","target", "consider" and similar expressions, are generally intended to identifyforward-looking statements. Such forward-looking statements involve known andunknown risks, uncertainties and other important factors (including, but notlimited to, the outcome of litigation, claims and regulatory approvals) thatcould cause the actual results, performance or achievements of Smith & Nephew,or industry results, to differ materially from any future results, performanceor achievements expressed or implied by such forward-looking statements. Pleaserefer to the documents that Smith & Nephew has filed with the U.S. Securitiesand Exchange Commission under the U.S. Securities Exchange Act of 1934, asamended, including Smith & Nephew's most recent annual report on Form 20F, for adiscussion of certain of these factors. All forward-looking statements in this press release are based on informationavailable to Smith & Nephew as of the date hereof. All written or oralforward-looking statements attributable to Smith & Nephew or any person actingon behalf of Smith & Nephew are expressly qualified in their entirety by theforegoing. Smith & Nephew does not undertake any obligation to update or reviseany forward-looking statement contained herein to reflect any change in Smith &Nephew's expectation with regard thereto or any change in events, conditions orcircumstances on which any such statement is based. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Smith & Nephew